<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00115063</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 25002</org_study_id>
    <nct_id>NCT00115063</nct_id>
  </id_info>
  <brief_title>LOSS- Louisiana Obese Subjects Study</brief_title>
  <acronym>LOSS</acronym>
  <official_title>Loss - Louisiana Obese Subjects Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Louisiana Office of Group Benefits</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      LOSS is a pragmatic clinical evaluation of intensive medical approaches to weight loss for
      individuals with extreme obesity (body mass index [BMI] 40-60 kg/m2). The intensive medical
      treatment is designed to produce 25% weight loss from baseline and to maintain at least 20%
      weight loss from baseline. The intensive medical treatment is compared to a usual care
      treatment model where individuals utilize self directed approaches to weight loss. The active
      treatment period is three years, followed by two years of observation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      LOSS is a pragmatic clinical trial designed to evaluate intensive medical treatment for
      patients with severe obesity who would otherwise qualify as candidates for obesity surgery
      and who are covered by the Louisiana Office of Group Benefits (OGB) Health Insurance. LOSS
      will track the efficacy, safety and costs to compare two patient management approaches -
      intensive medical treatment, or a usual medical care treatment model. Recruitment will be
      done by mailers to insured patients to identify eligible candidates. We will randomly assign
      eligible volunteers to intensive medical treatment (n=240) or usual care (n=240). Patients
      will be evaluated annually and medical treatments are given in eight clinics around
      Louisiana. The eight sites are in Alexandria, Baton Rouge, Lafayette, Lake Charles, Monroe,
      Hammond, New Orleans and Shreveport.

      Hypothesis:

      We hypothesize that we can achieve weight loss after two and five years that exceeds 20% from
      baseline with intensive medical management of persons with class III obesity and that this
      weight loss is greater than that achieved with usual medical care including access to a
      weight management web site.

      Our secondary hypotheses are: 1) that the weight loss at year 2 and 5 in the intensive
      medical group is associated with improvements in blood pressure, fasting glucose, lipids,
      health-related quality of life and psychosocial measures and is greater improvement than that
      achieved with usual medical care and access to a website; and 2) that total medical costs in
      the intensive medical management group will compare favorably to total medical costs in the
      usual care group (i.e., total reimbursement from insurance costs will be less, even when the
      expense of the treatment is considered).

      Overall Aim:

      The overarching aim of this study is to observe the effect of an intensive medical management
      program versus usual care for class III obesity on weight loss, total medical costs and, on
      measures of health risks associated with weight loss (blood pressure, blood glucose, blood
      lipids, and health-related quality of life).

      Specific Aims:

      Primary: The primary specific aim of the LOSS study is to test the hypothesis that the weight
      loss efficacy at years 2 and 5 for an intensive medical treatment program for Class III
      obesity produces greater weight loss, as compared to a condition of usual care.

      Secondary: The secondary aims of the study are:

        -  To evaluate the percent change in body weight, absolute change in body weight
           (kilograms) and percent excess weight lost from baseline at months 3, 6, 12, 24, 36, 48
           and 60 for medically treated patient groups, and at years 1, 2, 3, 4 and 5 for both
           groups.

        -  To evaluate the number and proportion of subjects who maintain 100% and 80% of 12 months
           weight lost at months 24, 36, 48 and 60 for medically treated patients and at years 2,
           3, 4 and 5 for both groups.

        -  To evaluate the changes from baseline in blood pressure, pulse rate, and efficacy
           laboratory parameters at visits on months 3, 6, 12, 24, 36, 48 and 60 for the medically
           treated patient group, and at years 1, 2, 3, 4 and 5 for both groups.

        -  To assess the safety and tolerability of the intervention regimens at months 3, 6, 12,
           24, 36, 48 and 60 for the medically treated patient group.

        -  To assess the total medical costs of the participants treated with intensive medical
           treatment and for the patients receiving usual care at years 1, 2, 3, 4 and 5.

        -  To assess additional psychosocial and economic measures (health-related quality of life,
           pain, depression, and stress) for the intervention group at months 4, 8, 12, 24, 36, 48
           and 60 months for both groups at years 1, 2, 3, 4, and 5.

        -  To compare subgroups of patients with class III obesity to determine if differences in
           outcome exist for gender, race, education level, decades of age and presence of
           co-morbid conditions.

      The Pennington Biomedical Research Center is the lead institution for the project. Pennington
      Management of Clinical Trials (PMCT) will serve as the Coordinating Center to manage
      enrollment and data acquisition and will report all data of health and cost results to a Data
      Safety Monitoring Board on a regular basis. Major data reports and scientific publications
      occur at years 2 and 5.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    ethical issues of continuing control group without treatment
  </why_stopped>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Change From Baseline Weight</measure>
    <time_frame>Baseline, 2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Weight From Baseline in Kilograms (kg)</measure>
    <time_frame>Baseline, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Blood Pressure</measure>
    <time_frame>Baseline, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Change in Blood Tests- Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), Triglycerides and Uric Acid</measure>
    <time_frame>Baseline, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fasting Plasma Glucose (FPG) in Milligrams Per Deciliter (mg/dL)</measure>
    <time_frame>Baseline, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Duke Activity Status Index (DASI) Questionnaire Score</measure>
    <time_frame>Baseline, 2 years</time_frame>
    <description>The DASI was used to access changes in fuctional capacity during the study. The highest score possible is 58.2 and the lowest is 0. The score for each individual question varied depending on the intensity of the activity being evaluated. The higher the score, the more physically active a person is to this set of activities of daily living questions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">390</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>group sessions</intervention_name>
    <description>group sessions lead by a trained primary care clinic employee</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sibutramine, orlistat, diethylpropion</intervention_name>
    <description>dosage modified according to package insert instructions at discretion of primary care physicians</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Calorie Diet, Health One</intervention_name>
    <description>liquid diet for 8-12 weeks to induce weight loss</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intensive Medical Combination Therapy for Obesity</intervention_name>
    <description>Very Low Calorie Liquid diet, Group Behavioral Therapy, Meal Replacement Therapy, Obesity Pharmacotherapy and a &quot;Treatment Toolbox&quot;.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Condition</intervention_name>
    <description>Access to the Mayo Clinic weight management website and usual care from the primary care physician</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant in the Exclusive Provider Organization (EPO), Managed Care Organization
             (MCO) and Preferred Provider Organization (PPO) programs of the Louisiana State
             Employees Group Benefits Health Insurance

          -  Agree to travel for treatment to the assigned study site

          -  Agree to randomized treatment assignment

          -  Male and females age 20-60 years

          -  Body Mass Index &gt;40kg/m2 but &lt; 60 kg/m2

          -  Females must be non-pregnant and using an approved contraception method

          -  Complete Blood Count (CBC): normal hematocrit, white count and platelet count, unless
             waived by Principal Investigator (PI)

          -  Uric Acid &lt;9.0 mg/dl

          -  Normal Creatinine

          -  Normal Thyroid Stimulating Hormone (TSH)

          -  Negative urine pregnancy test for women of childbearing potential

          -  Able to give written informed consent

          -  Able to comply with study procedures

        Exclusion Criteria:

        Factors that may limit adherence to interventions or affect conduct of the trial:

          -  Unable or unwilling to give informed consent or communicate with local study staff

          -  Hospitalization for psychiatric illness or substance use/abuse within the past year

          -  Self-report of alcohol or substance abuse within the past twelve months

          -  Current major depressive episode or history of suicidal behaviors

          -  Endorsement of significant recent suicidal ideation (as determined by PI)

          -  Travel plans that do not permit participation

          -  History of prior bariatric surgery, small bowel resection, or extensive bowel
             resection

          -  Current use of chronic systemic corticosteroids, appetite suppressants, antipsychotic
             medication, herbal medications for weight loss or any medication not approved by the
             PI.

          -  Another member of the household is a participant or staff member in the study

          -  History of eating disorder such as anorexia nervosa, bulimia, or binge eating

          -  Diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, or
             personality disorder (as determined by the PI)

          -  Currently pregnant or nursing or plans to become pregnant in the next five years

          -  Except for non-melanoma skin cancer, cancer requiring treatment in the past five
             years, unless the prognosis is excellent

          -  Self report of Human Immunodeficiency Virus (HIV) positive, hepatitis C or active
             tuberculosis

          -  Cardiovascular disease event within the past year

          -  Severe congestive heart failure (New York Heart Association [NYHA] Functional Class
             III, IV)

          -  Second degree or greater heart block

          -  Blood Pressure &gt;160 systolic or &gt;100 diastolic on two consecutive visits, unless
             treated and re-screened

          -  Based upon responses to psychological screening or an interview, patients may be
             excluded by the study psychologist.

          -  Other medical, psychiatric, or behavioral limitations that in the judgment of the
             investigator may interfere with study participation or the ability to follow the
             intervention protocol.

          -  Pregnancy is to be avoided during the study. Women who have not had a hysterectomy or
             oophorectomy must have a negative urine pregnancy test result at screening. Women of
             childbearing potential will be allowed to participate if they have undergone tubal
             ligation, or use one of the following types of contraception: properly used condom or
             diaphragm, oral contraceptives, hormonal implant, or intrauterine device (IUD). Sexual
             abstinence may constitute an acceptable birth control method for this study with
             investigator approval. Women with male partners who have had a successful vasectomy
             (more than one year of unprotected sexual intercourse without pregnancy) are not
             required to use additional birth control methods as long as the relationship remains
             exclusive, and the woman agrees to use an approved contraception method with any other
             male partner. Questions regarding individual patient contraceptive practices should be
             directed to the Principal Investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donna H Ryan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pennington Management of Clinical Trials</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pbrc.edu</url>
    <description>Pennington Biomedical Research Center home page</description>
  </link>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2005</study_first_submitted>
  <study_first_submitted_qc>June 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2005</study_first_posted>
  <results_first_submitted>March 1, 2010</results_first_submitted>
  <results_first_submitted_qc>May 6, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 7, 2010</results_first_posted>
  <last_update_submitted>January 22, 2016</last_update_submitted>
  <last_update_submitted_qc>January 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Donna H. Ryan, MD</investigator_full_name>
    <investigator_title>Professor, Adjunct</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>Low Calorie Diet</keyword>
  <keyword>Obesity Pharmacotherapy</keyword>
  <keyword>Pragmatic Clinical Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Orlistat</mesh_term>
    <mesh_term>Sibutramine</mesh_term>
    <mesh_term>Diethylpropion</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intensive Medical Intervention</title>
          <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
        </group>
        <group group_id="P2">
          <title>Access to Weight Loss Informational Website</title>
          <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="200"/>
                <participants group_id="P2" count="190"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="101"/>
                <participants group_id="P2" count="86"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="99"/>
                <participants group_id="P2" count="104"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="98"/>
                <participants group_id="P2" count="104"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intensive Medical Intervention</title>
          <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
        </group>
        <group group_id="B2">
          <title>Access to Weight Loss Informational Website</title>
          <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="200"/>
            <count group_id="B2" value="190"/>
            <count group_id="B3" value="390"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="200"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="390"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.2" spread="0.6"/>
                    <measurement group_id="B2" value="47.1" spread="0.6"/>
                    <measurement group_id="B3" value="47.2" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="167"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="326"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="149"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="200"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="390"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Change From Baseline Weight</title>
        <time_frame>Baseline, 2 years</time_frame>
        <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Intensive Medical Intervention</title>
            <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
          </group>
          <group group_id="O2">
            <title>Access to Weight Loss Informational Website</title>
            <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change From Baseline Weight</title>
          <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
          <units>Percent change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.7" spread="1.3"/>
                    <measurement group_id="O2" value="-0.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Weight From Baseline in Kilograms (kg)</title>
        <time_frame>Baseline, 2 years</time_frame>
        <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Intensive Medical Intervention</title>
            <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
          </group>
          <group group_id="O2">
            <title>Access to Weight Loss Informational Website</title>
            <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Weight From Baseline in Kilograms (kg)</title>
          <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-12.7" spread="1.7"/>
                    <measurement group_id="O2" value="-0.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Blood Pressure</title>
        <time_frame>Baseline, 2 years</time_frame>
        <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Intensive Medical Intervention</title>
            <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
          </group>
          <group group_id="O2">
            <title>Access to Weight Loss Informational Website</title>
            <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Blood Pressure</title>
          <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
          <units>millimeter of mercury (mm Hg)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>systolic blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.7" spread="2.4"/>
                    <measurement group_id="O2" value="-8.6" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>dystolic blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.4" spread="1.8"/>
                    <measurement group_id="O2" value="-3.2" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.09</p_value>
            <p_value_desc>P-value for systolic blood pressure mean.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.60</p_value>
            <p_value_desc>P-value for dystolic blood pressure mean.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Change in Blood Tests- Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), Triglycerides and Uric Acid</title>
        <time_frame>Baseline, 2 years</time_frame>
        <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Intensive Medical Intervention</title>
            <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
          </group>
          <group group_id="O2">
            <title>Access to Weight Loss Informational Website</title>
            <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Blood Tests- Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), Triglycerides and Uric Acid</title>
          <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
          <units>Percent change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>LDL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="2.4"/>
                    <measurement group_id="O2" value="0.7" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="1.8"/>
                    <measurement group_id="O2" value="1.5" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Triglycerides</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.2" spread="3.5"/>
                    <measurement group_id="O2" value="-4.8" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric Acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="2.4"/>
                    <measurement group_id="O2" value="3.1" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.73</p_value>
            <p_value_desc>P-value for LDL cholesterol</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <p_value_desc>P-value for HDL cholesterol</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.42</p_value>
            <p_value_desc>P-value for triglycerides</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.05</p_value>
            <p_value_desc>P-value for uric acid</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Fasting Plasma Glucose (FPG) in Milligrams Per Deciliter (mg/dL)</title>
        <time_frame>Baseline, 2 years</time_frame>
        <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Intensive Medical Intervention</title>
            <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
          </group>
          <group group_id="O2">
            <title>Access to Weight Loss Informational Website</title>
            <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fasting Plasma Glucose (FPG) in Milligrams Per Deciliter (mg/dL)</title>
          <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="2.1"/>
                    <measurement group_id="O2" value="6.7" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.16</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Duke Activity Status Index (DASI) Questionnaire Score</title>
        <description>The DASI was used to access changes in fuctional capacity during the study. The highest score possible is 58.2 and the lowest is 0. The score for each individual question varied depending on the intensity of the activity being evaluated. The higher the score, the more physically active a person is to this set of activities of daily living questions.</description>
        <time_frame>Baseline, 2 years</time_frame>
        <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Intensive Medical Intervention</title>
            <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
          </group>
          <group group_id="O2">
            <title>Access to Weight Loss Informational Website</title>
            <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Duke Activity Status Index (DASI) Questionnaire Score</title>
          <description>The DASI was used to access changes in fuctional capacity during the study. The highest score possible is 58.2 and the lowest is 0. The score for each individual question varied depending on the intensity of the activity being evaluated. The higher the score, the more physically active a person is to this set of activities of daily living questions.</description>
          <population>This analysis was done on the completers, those that completed the 2 year study visit.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.1" spread="1.7"/>
                    <measurement group_id="O2" value="-11.6" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Serious adverse events were collected at all study visits for both groups from study start to 2 years.</time_frame>
      <desc>Only serious adverse events were tracked for this study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Intensive Medical Intervention</title>
          <description>Intensive Medical Intervention including Low Calorie Liquid Diet, Weight loss medications, Group Behavioral Therapy and a &quot;Tool Box&quot; approach</description>
        </group>
        <group group_id="E2">
          <title>Access to Weight Loss Informational Website</title>
          <description>Access to Weight Loss Informational Website sponsored by the Mayo Clinic</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="200"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chest heaviness</sub_title>
                <description>Referred to cardiologist</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Elevated blood pressure and mood swings</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <description>One patient reported chest pain and underwent a angiograpy, results were normal. A second patient reported chest pain and was hospitalized, diagnosed with dehydration.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <description>Due to myocardial infarction</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>New-onset atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Hospitalization for acute myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="200"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hernia repair</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Bleeding duodenal ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for hypokalemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="200"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for arm fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Cervical disk surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Total knee replacement surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Hospitalization for back surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="200"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="200"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for hallucinations</sub_title>
                <description>Patient had history of mental illness</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Surgery for cyctocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Hospitalization for nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Hysterectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="200"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Hospitalization for asthma and bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Surgical incision and drainage of abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Pacemaker insertion procedure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="200"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Hospitalization for stent placement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="200"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for coronary stent replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>Hospitalization for deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="200"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>4</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was stopped prematurely for efforts to be focused on assisting the Office of Group Benefits (OGB) in translating a policy that would allow for physician certification in order to offer participants the intensive treatment.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Tiffany Prather, RN, CDE</name_or_title>
      <organization>PenningtonBRC</organization>
      <phone>225-763-2979</phone>
      <email>tiffany.prather@pbrc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

